Oral contraceptive use in women at increased risk of breast/ovarian cancer: Knowledge and attitudes

Psycho-Oncology

Volumn 22, Issue 1, 2013, Pages 228-232

  Bui, Kim Tam ^a   Wakefield, Claire E ^a,b   Kasparian, Nadine A ^a   Tyler, Janet ^c   Abbott, Jason ^a,d   Tucker, Kathy ^c,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d Royal Hospital for Women   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cancer; contraceptives; hereditary breast ovarian cancer; information needs; oncology

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; AVOIDANCE BEHAVIOR; BREAST CANCER; CANCER RISK; CONDOM; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC RISK; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; ORAL CONTRACEPTION; OVARIECTOMY; OVARY CANCER; QUESTIONNAIRE; RECALL; SCORING SYSTEM; SELF REPORT; SEXUAL BEHAVIOR; UTERINE CERVIX CAP; UTERINE TUBE LIGATION; VASECTOMY;

ADOLESCENT; ADULT; AUSTRALIA; BREAST NEOPLASMS; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 84872088560     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2049     Document Type: Article

References (21)

1. ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update 2005; 11: 513-525.
2. La Vecchia C, Bosetti C,. Benefits and risks of oral contraceptives on cancer. Eur J Cancer Prev 2004; 13: 467-470.
3. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet 2008; 371: 303-314.
4. Metcalfe KA, Finch A, Poll A, et al., Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br J Cancer 2009; 100: 421-425.
5. Soegaard M, Frederiksen K, Jensen A, et al., Risk of ovarian cancer in women with first-degree relatives with cancer. Acta Obstet Gynecol Scand 2009; 88: 449-456.
6. Milne RL, Knight JA, John EM, et al., Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2005; 14: 305-356.
7. Brohet RM, Goldgar DE, Easton DF, et al., Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENESPO, GEO-HEBON, and the IBCCS Collaborating Group. J Clin Oncol 2007; 25: 3831-3836.
8. Grabrick DM, Hartmann LC, Cerhan JR, et al., Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 2000; 284: 1791-1798.
9. Silvera SAN, Miller AB, Rohan TE,. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study. Cancer Causes Control 2005; 16: 1059-1063.
10. Haile RW, Thomas DC, McGuire V, et al., BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev 2006; 15: 1863-1870.
11. Jensen JT, Speroff L,. Health benefits of oral contraceptives. Obstet Gynecol Clin North Am 2000; 27: 705-721.
12. Burke AE, Blumenthal PD,. Successful use of oral contraceptive. Semin Reprod Med 2001; 19: 313-321.
13. Bryden PJ, Fletcher P,. Knowledge of the risks and benefits associated with oral contraception in a university-aged sample of users and non-users. Contraception 2001; 63: 223-227.
14. National Breast Cancer Centre. Advice about the Familial Aspects of Breast Cancer and Epithelial Ovarian Cancer: A Guide for Health Professionals. National Breast Cancer Centre: Camperdown, 2006.
15. Philipson S, Kasparian N, Wakefield CE,. Women's knowledge, beliefs and information needs in relation to the risks and benefits associated with use of the oral contraceptive pill. J Womens Health 2011; 20: 635-642.
16. Zigmond AS, Snaith RP,. The hospital and anxiety depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
17. Halel S, Ali N, Posner S, et al., Disparities in contraceptive knowledge, attitude and use between Hispanic and non-Hispanic whites. Contraception 2006; 74: 125-132.
18. Chebaro R, El Tayyara L, Ghazzawi F, et al., Knowledge, attitudes and practices about contraception in an urban population. East Mediterr Health J 2005; 11: 573-585.
19. Junghans C, Feder G, Hemingway H, et al., Recruiting patients to medical research: double blind randomised trial of " opt-in" versus " opt-out" strategies. Br Med J 2005; 331: 940.
20. Iglesias C, Torgerson D,. Does length of questionnaire matter? A randomised trial of response rates to a mailed questionnaire. J Health Serv Res Policy 2000; 5: 219-221.
21. Nakash RA, Hutton JL, Jorstad-Stein EC, et al., Maximising response to postal questionnaires-a systematic review of randomised trials in health research. BMC Med Res Methodol 2006; 6: 5.